Industry News

Jun 04, 2018
By BioPharm International Editors
The company is recalling two lots of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system due to particulate matter on the syringe plunger.
Jun 04, 2018
By BioPharm International Editors
The FDA commissioner announced proposed steps to modernize the organization and functions of CDER’s Office of New Drugs.
Jun 01, 2018
By BioPharm International Editors
The Amgen Foundation and Harvard University will develop LabXchange, a free online science education platform that will provide digital instruction and virtual lab experiences.
Jun 01, 2018
By BioPharm International Editors
National Institutes of Health researchers combine two microscope technologies to create sharper, faster images.
May 31, 2018
By BioPharm International Editors
The agency published two guidance documents to address brand drug makers’ use of REMS to block generic-drug development.
May 31, 2018
By BioPharm International Editors
Ingenza, in partnership with the University of Dundee and Drochaid Research Services, will work on a project to recycle CO2 emissions from bioprocessing plants to serve as feedstock and energy inputs.
May 30, 2018
By BioPharm International Editors
World Health Organization’s Ebola ring vaccination uses Merck & Co.’s investigational rVSV-ZEBOV vaccine to protect high-risk communities in the Democratic Republic of the Congo from Ebola.
May 30, 2018
By BioPharm International Editors
FDA sent a warning letter to Jilin Shulan Synthetic Pharmaceutical Co., Ltd. after an inspection found CGMP violations including a lack of data integrity.
May 30, 2018
By BioPharm International Editors
The new draft guidance addresses the premarketing assessment of a drug’s effect on blood pressure.
May 23, 2018
Right-to-Try bill sent to White House for President’s signature after passage by Congress.
native1_300x100
lorem ipsum